The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro-Reference-Cited by-同舟云学术

The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro

Published:2020-11-09 Issue:6 Volume:70 Page:1771-1776
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Presti Mario^ORCID,Westergaard Marie Christine Wulff^ORCID,Draghi Arianna^ORCID,Chamberlain Christopher Aled^ORCID,Gokuldass Aishwarya,Svane Inge Marie^ORCID,Donia Marco^ORCID

Funder

Kræftens Bekæmpelse

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-020-02760-z.pdf

Reference28 articles.

1. Kelly PN (2018) Special section the cancer immunotherapy revolution. Science 359:1344–1345. https://doi.org/10.1126/science.359.6382.1344

2. Wei SC, Duffy CR, Allison JP (2018) Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov 8:1069–1086

3. Fife BT, Pauken KE, Eagar TN et al (2009) Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol 10:1185–1192. https://doi.org/10.1038/ni.1790

4. Michot JM, Bigenwald C, Champiat S et al (2016) Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer 54:139–148. https://doi.org/10.1016/j.ejca.2015.11.016

5. IQVIA (2019) Global oncology trends 2019. https://www.iqvia.com/insights/the-iqvia-institute/reports/global-oncology-trends-2019. Accessed 28 Oct 2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential severe immune-related adverse events induced by PD-1 inhibitor: a case report and literature review;Frontiers in Oncology;2024-07-29

2. Effects of immune‐related adverse events (irAEs) and their treatment on antitumor immune responses;Immunological Reviews;2023-08-14

3. Immune Checkpoint Inhibitor-related Pancreatitis: A Case Series, Review of the Literature and an Expert Opinion;Journal of Immunotherapy;2023-05-23

4. Tacrolimus for the Management of Delayed Onset and Treatment-Refractory Immune-Related Hepatitis;ACG Case Reports Journal;2023-04

5. Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma;Aging;2022-12-03